169 related articles for article (PubMed ID: 32348877)
1. Chemical evolution for taming the 'pathogenic kinase' PAK1.
Maruta H; Kittaka A
Drug Discov Today; 2020 Jun; 25(6):959-964. PubMed ID: 32348877
[TBL] [Abstract][Full Text] [Related]
2. From bench (laboratory) to bed (hospital/home): How to explore effective natural and synthetic PAK1-blockers/longevity-promoters for cancer therapy.
Maruta H; Ahn MR
Eur J Med Chem; 2017 Dec; 142():229-243. PubMed ID: 28814374
[TBL] [Abstract][Full Text] [Related]
3. Herbal therapeutics that block the oncogenic kinase PAK1: a practical approach towards PAK1-dependent diseases and longevity.
Maruta H
Phytother Res; 2014 May; 28(5):656-72. PubMed ID: 23943274
[TBL] [Abstract][Full Text] [Related]
4. 1,2,3-Triazolyl ester of Ketorolac: A "Click Chemistry"-based highly potent PAK1-blocking cancer-killer.
Nguyen BCQ; Takahashi H; Uto Y; Shahinozzaman MD; Tawata S; Maruta H
Eur J Med Chem; 2017 Jan; 126():270-276. PubMed ID: 27889630
[TBL] [Abstract][Full Text] [Related]
5. P21 activated kinase signaling in cancer.
Rane CK; Minden A
Semin Cancer Biol; 2019 Feb; 54():40-49. PubMed ID: 29330094
[TBL] [Abstract][Full Text] [Related]
6. p21-Activated kinase 1 (PAK1) in aging and longevity: An overview.
Amirthalingam M; Palanisamy S; Tawata S
Ageing Res Rev; 2021 Nov; 71():101443. PubMed ID: 34390849
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of p21-activated kinases (PAKs).
Rudolph J; Crawford JJ; Hoeflich KP; Wang W
J Med Chem; 2015 Jan; 58(1):111-29. PubMed ID: 25415869
[TBL] [Abstract][Full Text] [Related]
8. Combination of immunoprecipitation (IP)-ATP_Glo kinase assay and melanogenesis for the assessment of potent and safe PAK1-blockers in cell culture.
Nguyen BC; Be Tu PT; Tawata S; Maruta H
Drug Discov Ther; 2015 Aug; 9(4):289-95. PubMed ID: 26370527
[TBL] [Abstract][Full Text] [Related]
9. Several herbal compounds in Okinawa plants directly inhibit the oncogenic/aging kinase PAK1.
Nguyen BC; Taira N; Tawata S
Drug Discov Ther; 2014 Dec; 8(6):238-44. PubMed ID: 25639302
[TBL] [Abstract][Full Text] [Related]
10. The subcellular localization of type I p21-activated kinases is controlled by the disordered variable region and polybasic sequences.
Sun X; Su VL; Calderwood DA
J Biol Chem; 2019 Sep; 294(39):14319-14332. PubMed ID: 31391252
[TBL] [Abstract][Full Text] [Related]
11. A GTPase-independent mechanism of p21-activated kinase activation. Regulation by sphingosine and other biologically active lipids.
Bokoch GM; Reilly AM; Daniels RH; King CC; Olivera A; Spiegel S; Knaus UG
J Biol Chem; 1998 Apr; 273(14):8137-44. PubMed ID: 9525917
[TBL] [Abstract][Full Text] [Related]
12. Role of p-21-activated kinases in cancer progression.
King H; Nicholas NS; Wells CM
Int Rev Cell Mol Biol; 2014; 309():347-87. PubMed ID: 24529727
[TBL] [Abstract][Full Text] [Related]
13. p21-activated kinase inhibitors.
Rudolph J; Crawford JJ; Hoeflich KP; Chernoff J
Enzymes; 2013; 34 Pt. B():157-80. PubMed ID: 25034104
[TBL] [Abstract][Full Text] [Related]
14. PAK1 as a therapeutic target.
Kichina JV; Goc A; Al-Husein B; Somanath PR; Kandel ES
Expert Opin Ther Targets; 2010 Jul; 14(7):703-25. PubMed ID: 20507214
[TBL] [Abstract][Full Text] [Related]
15. Development of small-molecule inhibitors of the group I p21-activated kinases, emerging therapeutic targets in cancer.
Yi C; Maksimoska J; Marmorstein R; Kissil JL
Biochem Pharmacol; 2010 Sep; 80(5):683-9. PubMed ID: 20302846
[TBL] [Abstract][Full Text] [Related]
16. 1,2,3-Triazolyl ester of ketorolac (15K): Boosting both heat-endurance and lifespan of C. elegans by down-regulating PAK1 at nM levels.
Nguyen BC; Kim SA; Won SM; Park SK; Uto Y; Maruta H
Drug Discov Ther; 2018; 12(2):92-96. PubMed ID: 29760342
[TBL] [Abstract][Full Text] [Related]
17. Effects of p21-activated kinase 1 inhibition on 11q13-amplified ovarian cancer cells.
Prudnikova TY; Villamar-Cruz O; Rawat SJ; Cai KQ; Chernoff J
Oncogene; 2016 Apr; 35(17):2178-85. PubMed ID: 26257058
[TBL] [Abstract][Full Text] [Related]
18. P21-activated kinase in inflammatory and cardiovascular disease.
Taglieri DM; Ushio-Fukai M; Monasky MM
Cell Signal; 2014 Sep; 26(9):2060-9. PubMed ID: 24794532
[TBL] [Abstract][Full Text] [Related]
19. Anti-cancer effect of novel PAK1 inhibitor via induction of PUMA-mediated cell death and p21-mediated cell cycle arrest.
Woo TG; Yoon MH; Hong SD; Choi J; Ha NC; Sun H; Park BJ
Oncotarget; 2017 Apr; 8(14):23690-23701. PubMed ID: 28423593
[TBL] [Abstract][Full Text] [Related]
20. Autophosphorylation-dependent degradation of Pak1, triggered by the Rho-family GTPase, Chp.
Weisz Hubsman M; Volinsky N; Manser E; Yablonski D; Aronheim A
Biochem J; 2007 Jun; 404(3):487-97. PubMed ID: 17355222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
